Renal denervation is a minimally invasive catheter-based procedure for the treatment of hypertension in patients. It is generally opted in cases where medicines fail to provide relief to the patient. In this procedure, nerves of the renal artery wall are ablated with the help of radiofrequency pulses or ultrasound. This leads to a reduction of sympathetic afferent and efferent kidney activity, which further leads to a reduction in blood pressure.
The world renal denervation market was $197 million in 2015 and is expected to reach $3,153 million by 2022 with a CAGR of 48.5%. The market is driven by factors such as changes in lifestyle of the people, which leads to uncontrolled, treatment resistant hypertension, and ageing population. In addition to this, technological advancements have helped in the development of innovative and efficient denervation devices that have driven the market growth. However, low awareness for renal denervation procedure, stringent regulatory norms for renal denervation systems, and unfavorable reimbursements for renal denervation procedure have restricted the growth of the market.
The report segments the market based on product, technology, and geography. Based on product, it is segmented into Symplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Paradise Renal Denervation System, and Iberis Renal Sympathetic Denervation System. Based on technology, the market is segmented into radiofrequency, ultrasound, and micro-infusion. Based on geography, the market is divided into four major regions, namely, North America (the U.S., Canada, and Mexico), Europe (Germany, France, U.K., Italy, and Spain), Asia-Pacific (Japan, China, India, Australia, and New Zealand), and LAMEA (Brazil, South Africa, and Saudi Arabia).
The market has witnessed product development and acquisitions in the recent years. These acquisitions have helped the major players to combine their forces with smaller players and enhance their business. In this regard, Boston Scientific Corporation acquired Vessix Vascular, Inc. (November 2012) and Medtonic plc acquired Ardian, Inc. (January 2011). Both Vessix Vascular, Inc. and Ardian, Inc. were the producers of renal denervation devices. However, due to smaller production capacities and limited geographical presence the systems were not popular in the market. However, after the acquisition these systems were produced on a large scale. This enabled Medtonic plc and Boston Scientific Corporation to emerge as the top leading companies for renal denervation devices.
Key players that operate in this market include Ablative Solutions, Inc., Boston Scientific Corporation, Cardiosonic Ltd, Kona Medical, Inc., Medtronic plc, Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, St. Jude Medical, Inc., and Terumo Medical Corporation.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
SIMILAR MARKET STUDIES
The Global Optical Slit Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Optical Slit industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Optical Slit market analysis is provided for the ...
June 2016 | $2800 | View Details >>
The United States Bioabsorbable Scaffolds Industry 2015 Deep Market Research Report is a professional and in-depth study on the current state of the Bioabsorbable Scaffolds industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Bioabsorbable Scaffolds market analysis is provided for ...
November 2015 | $3800 | View Details >>
2016 Global Medical LMA Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Medical LMA industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Medical ...
November 2016 | $2850 | View Details >>
Notes: Production, means the output of Crutches Revenue, means the sales value of Crutches This report studies Crutches in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Cardinal Health ...
February 2017 | $2900 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research